Laboratorio Reig Jofre : Forté Pharma launches Expert Anti-chute in its main european markets
September 04, 2018 at 03:42 am EDT
Share
Forté Pharma, Reig Jofre's nutritional supplements line, extends the hairline of the beauty range with the launch of Expert Anti-chute, a new hair care supplement in a single tablet for hormonal hair loss, especially recommended in male hereditary alopecia, female alopecia due to hormonal changes or prolonged stress, and alopecia areata.
Its advanced formula, result of Forté Pharma's R&D team research, provides the double action of helping regulate hyper-seborrhea, causative factor of hair follicle weakening and of boosting the growth. The unique and synergistic combination and the high concentration of its natural-origin ingredients contributes to nourish the capillary bulb, activate the microcirculation and protect from the oxidation derived from free radicals.
Forté Pharma launched Expert Anti-chute in Spain, France, Belgium and Portugal, main markets of the company and contemplates its future expansion to other markets where the brand is present.
Descargue el documento completo (PDF)
Attachments
Original document
Permalink
Disclaimer
Laboratorio Reig Jofre SA published this content on 04 September 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 04 September 2018 07:41:03 UTC
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Companyâs activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.